Bradford Crutchfield, Chief Commercial Officer at 10x Genomics, Inc. (TXG), sold 31,000 shares at $138.97 ($4.3M) on 2021-01-04, disclosed to the SEC on 2021-01-06.
Open-market sale of $4.3M TXG by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $138.97 | 3,000 | $417K | 9.6% |
| 2 | $139.89 | 10,465 | $1.5M | 33.7% |
| 3 | $139.89 | 10,465 | $1.5M | 33.7% |
| 4 | $140.74 | 3,135 | $441K | 10.2% |
| 5 | $140.74 | 3,135 | $441K | 10.2% |
| 6 | $141.77 | 400 |
| $57K |
| 1.3% |
| 7 | $141.77 | 400 | $57K | 1.3% |
| Total | $140.02 avg | 31,000 | $4.3M | 100% |
| Filing → |
| TXG | SELL | 2022-02-24 | $23K | — | Filing → |
| TXG | SELL | 2022-02-17 | $1.6M | — | Filing → |
| TXG | SELL | 2022-01-14 | $3.5M | — | Filing → |